Dr. Gholami is a board-certified surgeon scientist at the UC Davis Comprehensive Cancer Center with dual fellowship training in Complex General Surgical Oncology and Hepatopancreatobiliary Surgery. At UC Davis, she has focused her efforts on building a multi-disciplinary liver surgery program with liver-directed therapies/regional therapies, including a hepatic artery infusion pump program in patients with hepatobiliary and metastatic malignancies. Her research explores hepatobiliary tumor genetics, microenvironment, and immune profiling, with current studies in ex-vivo immune modeling of colorectal liver metastases (CRLM) which have been funded by the Association of Women Surgeons, Society of Surgical Oncology, and the Association of Academic Surgery Foundation. She also has a vested interest in translational science and clinical trials using neoadjuvant drug development strategies for CRLM such as immunotherapeutic anti-cancer treatments in combination with other standard cytotoxic cancer therapies.

Sepideh Gholami MD FACS
Hepatobiliary and Pancreatic Surgical Oncology
Assistant Professor, Department of Surgery